Health Officials Will Begin First Ebola Treatment Trials in West Africa
September 23, 2014
(Washington Post) – Although experimental treatments for the Ebola virus have already been administered to westerners who contracted the disease, scientists in London, with the help of international aid groups, plan on bringing clinical trials for those treatments to West Africa for the first time. The trials could begin in a matter of months. Wellcome Trust’s $5 million initiative will include drugs from Mapp Biopharmaceutical, Sarepta and Tekmira, according to Reuters. Mapp makes zMapp, the experimental cocktail administered to two Americans who contracted the disease in Liberia. And Tekmira recently gained the approval of the U.S. Food and Drug Administration to use its TKM-Ebola treatment on confirmed or suspected cases of the disease.